A report from Gartner says that 3D printing will create debate on ethics and regulation. Furthermore, analysts expect that rapid development of 3D Bioprinters will spark calls to ban the technology for human and non-human use by 2016. 3D bioprinting is the medical application of 3D printing to produce living tissue and organs. It is progressing so quickly that it analysts at Gartner believe it will spark a major ethical debate on its use by 2016.
The technology of 3D “bioprinting” (the medical application of 3D printing to produce living tissue and organs) is advancing so quickly that it will spark a major ethical debate on its use by 2016, according to Gartner Inc. At the same time, 3D printing of non-living medical devices such as prosthetic limbs, combined with a burgeoning population and insufficient levels of healthcare in emerging markets, is likely to cause an explosion in demand for the technology by 2015. “3D bioprinting facilities with the ability to print human organs and tissue will advance far faster than general understanding and acceptance of the ramifications of this technology,” said Pete Basiliere, research director at Gartner.